Zimmer Biomet Holdings (ZBH) Net Margin (2009 - 2026)

Zimmer Biomet Holdings has reported Net Margin for 18 years, with the latest figure at 9.17% in Q2 2026.

• On a quarterly basis, Net Margin rose 178.0% year-over-year to 9.17% in Q2 2026; TTM through Jun 2026 was 9.96%, a 3.0% increase from a year earlier, with the FY2025 full-year figure at 9.06%, down 211.0% from the prior year.
• Net Margin was 9.17% for Q2 2026 at Zimmer Biomet Holdings, down from 11.42% in the prior quarter.
• The five-year high for Net Margin was 16.67% in Q4 2023, with the low at 0.87% in Q1 2022.
• Average Net Margin over 5 years is 9.75%, with a median of 9.53% recorded in 2024.
• The sharpest annual moves came in 2022 and 2023: Net Margin tumbled 1148 bps in 2022, then surged 1405 bps in 2023.
• Over 5 years, Net Margin stood at 2.62% in 2022, then surged by 536 bps to 16.67% in 2023, then plunged by 43 bps to 9.51% in 2024, then dropped by 16 bps to 7.94% in 2025, then increased by 15 bps to 9.17% in 2026.
• The last three Net Margin figures came in at 9.17% (Q2 2026), 11.42% (Q1 2026), and 7.94% (Q4 2025), per Business Quant data.